CSIMarket
 
Can B Corp   (CANB)
Other Ticker:  
 
 
Price: $0.0250 $0.00 0.000%
Day's High: $0.0272 Week Perf: 31.58 %
Day's Low: $ 0.02 30 Day Perf: 152.53 %
Volume (M): 336 52 Wk High: $ 0.17
Volume (M$): $ 8 52 Wk Avg: $0.03
Open: $0.02 52 Wk Low: $0.00



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 55
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Can B Corp

The Company operates several divisions, including document management and email marketing platforms; however, its primary operations are from the development and sale of products containing CBD. The Company’s products contain CBD derived from Hemp and include products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. In addition to offering white labeled products, Canbiola is developing its own line of proprietary products, as well as seeking synergistic value through acquisitions in the Hemp industry. Canbiola aims to be the premier provider of the highest quality natural Hemp CBD products on the market through sourcing the very best raw material and developing a variety of products we believe will improve peoples lives in a variety of areas.

Cannabidiol (“CBD”) is one of nearly 85 naturally occurring compounds (cannabinoids) found in industrial hemp and cannabis. CBD is non-psychoactive and is thought to have numerous uses, including, but not limited to, for pain, insomnia, epilepsy, anxiety, inflammation, and nausea. Unlike CBD derived from marijuana, CBD derived from the seeds and stalks of industrial hemp is generally considered “legal” in the U.S. so long as it contains less than 0.03% of “THC,” another, but psychoactive, cannabinoid found in cannabis. CBD derived from marijuana, marijuana and other marijuana derivatives are federally illegal in the U.S. under the Controlled Substances Act, despite being medically or recreationally legal in numerous states.

In order to facilitate its operations, the Company has entered into a Production Agreement with Pure Health Products, LLC, a New York limited liability company (“PHP”). Pursuant to the Production Agreement, PHP will manufacture, package, and sell the Company’s CBD infused products on an exclusive basis. PHP will not produce or manufacture any product containing any cannabis or hemp derivative for any person or entity other than the Company, and the Company controls the ingredients, recipe, manufacturing processes and procedures and quality and taste parameters for all Products produced at the PHP facility. PHP may also white label / rebrand or relabel the products on the Company’s behalf pursuant to “white label agreements” entered into between the Company and third-party customers. Through its contractual relationship with PHP, the Company is able to control the manufacturing process of its products while reducing its production costs. In addition, the Company has the option to acquire certain assets of PHP should it elect to take over direct manufacture of its Products.

The Company’s products are sold via its website and through doctors and other medical professionals with which the Company enters into distribution agreements.

The CBD and cannabis markets are flooded with competition ranging from mom and pop operations to multi-million-dollar conglomerates, many with longer operating histories, more capital and/or more industry knowledge than the Company. The Company hopes to partner with or engage industry specialists to help set it apart from its numerous competitors.

The statements found herein have not been evaluated by the Food and Drug Administration (FDA) and the Company’s products are not intended to diagnose, treat, cure or prevent any disease or medical condition.

While the Company is seeking additional opportunities to manufacture, market and/or distribute CBD, it continues to operate its Bullseye and WRAPmail divisions and explore ways to grow each, especially in a manner that would be symbiotic with its intended future CBD operation.

WRAPmail

The Company owns a patented technology that combines custom marketing content with organization e-mail to provide a next generation marketing platform for organizations and personal use. WRAPmail provides a branding and advertising solution to organizations allowing employee e-mails to be written on company sanctioned trackable e-mail stationary as opposed to using simple, personal e-mail signatures. In essence, WRAPmail turns every e-mail sent by one of our customers into valuable marketing tool by “wrapping” the e-mail with the customer’s letterhead, logo, product offerings, or other information or graphics that the customer wishes to disseminate to the reader.

WRAPmail is a server/cloud- based solution. Users create e-mails just as they always have, and do not see the rich content. Users are not required to change their e-mail address and the administrator can “construct” with or without the help of the WRAPmail Production & Design team different e-mail letterheads using the included WRAPmaker that allow for including different graphics, links, promotions, surveys and/or audio. The e-mail either makes a stop after leaving the user’s desktop and that “stop” is where the e-mail gets wrapped or users use the available WRAPmail toolbars. Currently, toolbars are available for Google Chrome, Microsoft Internet Explorer, Apple Safari and Firefox for Gmail, Yahoo Mail, AOLMail, Microsoft Hotmail/LIVE, GoDaddy webmail, Keller Williams webmail, Salesforce.com webmail and 24sevenoffice.com webmail. WRAPmail software resides in the cloud or for large clients on their own server inside their Firewall. One WRAPmail server can currently process about 100K emails per hour (as we move to multi-threading we believe we can increase the speed ten-fold). WRAPmail has also developed an APP for Android and iPhone where users can send WRAPPED emails from their Gmail, Yahoo Mail, AOL Mail and Microsoft Mail.

Bullseye

The Bullseye Productivity Suite is a cloud-based system that consolidates all necessary office productivity tools into one online experience, accessible everywhere when you need it with full disaster recovery mechanisms built in. All functions and features are audited to help users with corporate governance and compliance issues.

The Bullseye® Productivity Suite consolidates all necessary office productivity tools into one online experience accessible everywhere you need it. The system has tools that include, but not limited to, close loop Email, CRM marketing, task and project management, document storage and retrieval system, note system, form building, video conferencing, scanning, internet cloud and real-time data use. All functions and features of the Bullseye® Productivity Suite are audited and help our clients with corporate governance and compliance. Flawless organization of personal and professional information as well as the categorizing and archiving of digital files is possible through our Bullseye platform.



   Company Address: 960 South Broadway Hicksville 11801 NY
   Company Phone Number: 595-9544   Stock Exchange / Ticker: CANB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Can B Corp

Can B Corp Reports Significant Losses of $-0.37 per Share, Reflecting Struggles in the Current Market


By
As a seasoned investor, I analyze financial reports rigorously, looking for patterns and insights that would aid in making informed decisions. This article aims to interpret the latest financial results of Can B Corp, shedding light on its dwindling performance and the subsequent impact on its share prices.
The financial interval ending June 30, 2023, reveals a concerning loss for Can B Corp. The company reported a loss of $-0.37 per share, showing a slight improvement over the previous year's loss of $-0.49 per share. However, it is a decline from the previous financial reporting period, where the loss stood at $-0.36 per share. Such losses illustrate the challenges faced by Can B Corp in the current market.

Can B Corp

Can B Corp Shows Financial Recovery in Fiscal Year End March 2023 with Significant Decrease in Losses and Surged Revenue

Can B Corp?s financial results for the fiscal period ending March 31, 2023, present a mixed picture for the company. On the positive side, the company has improved its loss per share, going from $-1.10 a year before to $-0.36 per share. Additionally, its Income per Share has improved from $-0.68 per share from the prior financial reporting period.
However, the picture isn?t all bright, as the company has experienced a significant drop in revenue. Revenue has decreased by 49.508% to $0.94 million from $1.86 million in the comparable financial reporting period a year prior. This decrease in revenue is a cause for concern as it may indicate that Can B Corp is not doing as well as previously thought. Nevertheless, sequentially, the revenue grew by 41.021% from $0.67 million, which is an improvement.







Can B's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com